Literature DB >> 15335303

Safety of benzodiazepines in the geriatric population.

Subramoniam Madhusoodanan1, Olivera J Bogunovic.   

Abstract

Benzodiazepines are the most frequently prescribed antianxiety drugs in the elderly. Despite their usefulness and safety in the younger population, there is concern about the rationale for their use in the elderly. Studies of the therapeutic use of benzodiazepines in the elderly are rare. Elderly females with co-morbid medical and psychiatric conditions and who are taking multiple medications form the group most frequently prescribed benzodiazepines among the elderly, and the group most likely to experience side effects. Age-related pharmacokinetic and pharmacodynamic changes increase the potential for certain side effects in the elderly. Significant adverse effects that may be associated with benzodiazepine use in the elderly include falls, cognitive impairment, sedation, and impairment of driving skills, all of which are particularly related to the long half-life of benzodiazepines. Long-term use of benzodiazepines should be discouraged because of the risk of dependence, which is a serious problem in the elderly. Unrecognised and untreated benzodiazepine dependence can lead to serious medical complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15335303     DOI: 10.1517/14740338.3.5.485

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  49 in total

1.  Prescription use disorders in older adults.

Authors:  Raj K Kalapatapu; Maria A Sullivan
Journal:  Am J Addict       Date:  2010-09-21

2.  [New use of benzodiazepines and the risk of hip fracture: A case-crossover study].

Authors:  F Hoffmann; G Glaeske
Journal:  Z Gerontol Geriatr       Date:  2006-04       Impact factor: 1.281

Review 3.  The effects of fall-risk-increasing drugs on postural control: a literature review.

Authors:  Maartje H de Groot; Jos P C M van Campen; Marije A Moek; Linda R Tulner; Jos H Beijnen; Claudine J C Lamoth
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

4.  Drinking, drugs and driving in Ireland: more evidence for action.

Authors:  P Fitzpatrick; L Daly; C P Leavy; D A Cusack
Journal:  Inj Prev       Date:  2006-12       Impact factor: 2.399

5.  The Effect of Computerized Physician Order Entry Template Modifications on the Administration of High-Risk Medications in Older Adults in the Emergency Department.

Authors:  Mitchell Kim; Stephen J Kaplan; Steven H Mitchell; Medley Gatewood; Itay Bentov; Katherine A Bennett; Carol A Crawford; Paul R Sutton; Diane Matsuwaka; Mamatha Damodarasamy; May J Reed
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

6.  Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013.

Authors:  Maria Gustafsson; Per-Olof Sandman; Stig Karlsson; Ulf Isaksson; Jörn Schneede; Maria Sjölander; Hugo Lövheim
Journal:  Eur J Clin Pharmacol       Date:  2015-02-26       Impact factor: 2.953

7.  Use of potentially inappropriate medications among ambulatory home-dwelling elderly patients with dementia: A review of the literature.

Authors:  Tejal Patel; Karen Slonim; Linda Lee
Journal:  Can Pharm J (Ott)       Date:  2017-05-01

8.  Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand.

Authors:  June M Tordoff; Nagham J Ailabouni; Dorothy P Browne; Hesham S Al-Sallami; Andrew R Gray
Journal:  Int J Clin Pharm       Date:  2016-05-30

9.  Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Majda Azermai; Luc Van Bortel; Mirko Petrovic; Robert R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2011-12-22       Impact factor: 2.953

10.  Medication management among home-dwelling older patients with chronic diseases: possible roles for community pharmacists.

Authors:  E Mehuys; L Dupond; M Petrovic; T Christiaens; L Van Bortel; E Adriaens; L De Bolle; I Van Tongelen; J-P Remon; K Boussery
Journal:  J Nutr Health Aging       Date:  2012-08       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.